Successful treatment of cranial dystonia using a Zolpidem+Melatonin combination: A video case-series

Cranial dystonias (CrD) are challenging to treat. Oral pharmacotherapy is often sub-optimal, while delicate anatomy and limited availability of skilled botulinum toxin injectors makes this approach risky, and often difficult to access; neurosurgical options e.g. deep brain stimulation, are high-risk in the elderly populations most affected.We observed significant improvement in CrD in 2 patients prescribed Zolpidem/Melatonin combination treatment for insomnia, and therefore trialled this treatment in a further 4 patients with CrD.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Tags: Clinical short communication Source Type: research